fda tirzepatide weight loss clinical trial results is FDA-approved for management, with trials showing average weight Zepbound vs Tirzepatide: Differences, Cost

In the SURMOUT-1 trial 2,539 patients underwent randomization to tirzepatide or placebo and were followed for 72 weeks demonstrating up to 20.9% weight reduction with maintenance dosing versus 3.1% in the placebo group for a net 17.8% weight reduction [35]

But the math shows why time-limited coverage is appealing to payers that struggle to pay for beneficiaries' GLP-1 prescriptions, said Michelle Gourdine, chief medical officer for the pharmacy benefit manager CVS Caremark

Most insurance companies including Cigna, UnitedHealthcare, Aetna, Blue Cross Blue Shield and Kaiser Permanente cover Wegovy

[PMID: 32554829]